Selected research
Industry Research
Pemetrexed Diacid Industry Research Report 2026
Market perspective
The global Pemetrexed Diacid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pemetrexed Diacid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pemetrexed Diacid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pemetrexed Diacid include Qilu Pharma, Nanjing Pharmaceutical Factory Co., Ltd., Lianyungang Tengfa Bio-tech Co., Ltd., Eli Lilly and Company, United Biotech India Pvt.Ltd., Pemgem, Onkos, Natco Pharma Ltd and Emcure, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pemetrexed Diacid market in terms of revenue (US$ million) and, where applicable, sales volume (doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pemetrexed Diacid Market by Company
Qilu Pharma
Nanjing Pharmaceutical Factory Co., Ltd.
Lianyungang Tengfa Bio-tech Co., Ltd.
Eli Lilly and Company
United Biotech India Pvt.Ltd.
Pemgem
Onkos
Natco Pharma Ltd
Emcure
Cytotoxic
ChemOthersapy
Beacon Pharma
Actiza Parma
Pemetrexed Diacid Segment by Type
500mg Injection
300mg Injection
200mg Injection
100mg Injection
Pemetrexed Diacid Segment by Application
Mesothelioma
Non-Small Cell Lung Cancer
Others
Pemetrexed Diacid Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Diacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Diacid and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Diacid.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pemetrexed Diacid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pemetrexed Diacid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 500mg Injection
- 300mg Injection
- 200mg Injection
- 100mg Injection
Applications
- Mesothelioma
- Non-Small Cell Lung Cancer
- Others
Companies covered
- Qilu Pharma
- Nanjing Pharmaceutical Factory Co., Ltd.
- Lianyungang Tengfa Bio-tech Co., Ltd.
- Eli Lilly and Company
- United Biotech India Pvt.Ltd.
- Pemgem
- Onkos
- Natco Pharma Ltd
- Emcure
- Cytotoxic
- ChemOthersapy
- Beacon Pharma
- Actiza Parma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Pemetrexed Diacid Market Size (2021-2032)
- 2.2.2 Global Pemetrexed Diacid Sales (2021-2032)
- 2.2.3 Global Pemetrexed Diacid Market Average Price (2021-2032)
- 2.3 Pemetrexed Diacid by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 500mg Injection
- 2.3.3 300mg Injection
- 2.3.4 200mg Injection
- 2.3.5 100mg Injection
- 2.4 Pemetrexed Diacid by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Mesothelioma
- 2.4.3 Non-Small Cell Lung Cancer
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pemetrexed Diacid Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Pemetrexed Diacid Sales (doses) of Manufacturers (2021-2026)
- 3.3 Global Pemetrexed Diacid Revenue of Manufacturers (2021-2026)
- 3.4 Global Pemetrexed Diacid Average Price by Manufacturers (2021-2026)
- 3.5 Global Pemetrexed Diacid Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Pemetrexed Diacid, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Pemetrexed Diacid, Product Type & Application
- 3.8 Global Manufacturers of Pemetrexed Diacid, Established Date
- 3.9 Global Pemetrexed Diacid Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Qilu Pharma
- 4.1.1 Qilu Pharma Company Information
- 4.1.2 Qilu Pharma Business Overview
- 4.1.3 Qilu Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
- 4.1.5 Qilu Pharma Recent Developments
- 4.2 Nanjing Pharmaceutical Factory Co., Ltd.
- 4.2.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
- 4.2.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
- 4.2.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
- 4.2.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
- 4.3 Lianyungang Tengfa Bio-tech Co., Ltd.
- 4.3.1 Lianyungang Tengfa Bio-tech Co., Ltd. Company Information
- 4.3.2 Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview
- 4.3.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
- 4.3.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments
- 4.4 Eli Lilly and Company
- 4.4.1 Eli Lilly and Company Company Information
- 4.4.2 Eli Lilly and Company Business Overview
- 4.4.3 Eli Lilly and Company Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
- 4.4.5 Eli Lilly and Company Recent Developments
- 4.5 United Biotech India Pvt.Ltd.
- 4.5.1 United Biotech India Pvt.Ltd. Company Information
- 4.5.2 United Biotech India Pvt.Ltd. Business Overview
- 4.5.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
- 4.5.5 United Biotech India Pvt.Ltd. Recent Developments
- 4.6 Pemgem
- 4.6.1 Pemgem Company Information
- 4.6.2 Pemgem Business Overview
- 4.6.3 Pemgem Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pemgem Pemetrexed Diacid Product Portfolio
- 4.6.5 Pemgem Recent Developments
- 4.7 Onkos
- 4.7.1 Onkos Company Information
- 4.7.2 Onkos Business Overview
- 4.7.3 Onkos Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Onkos Pemetrexed Diacid Product Portfolio
- 4.7.5 Onkos Recent Developments
- 4.8 Natco Pharma Ltd
- 4.8.1 Natco Pharma Ltd Company Information
- 4.8.2 Natco Pharma Ltd Business Overview
- 4.8.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
- 4.8.5 Natco Pharma Ltd Recent Developments
- 4.9 Emcure
- 4.9.1 Emcure Company Information
- 4.9.2 Emcure Business Overview
- 4.9.3 Emcure Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Emcure Pemetrexed Diacid Product Portfolio
- 4.9.5 Emcure Recent Developments
- 4.10 Cytotoxic
- 4.10.1 Cytotoxic Company Information
- 4.10.2 Cytotoxic Business Overview
- 4.10.3 Cytotoxic Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cytotoxic Pemetrexed Diacid Product Portfolio
- 4.10.5 Cytotoxic Recent Developments
- 4.11 ChemOthersapy
- 4.11.1 ChemOthersapy Company Information
- 4.11.2 ChemOthersapy Business Overview
- 4.11.3 ChemOthersapy Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
- 4.11.5 ChemOthersapy Recent Developments
- 4.12 Beacon Pharma
- 4.12.1 Beacon Pharma Company Information
- 4.12.2 Beacon Pharma Business Overview
- 4.12.3 Beacon Pharma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
- 4.12.5 Beacon Pharma Recent Developments
- 4.13 Actiza Parma
- 4.13.1 Actiza Parma Company Information
- 4.13.2 Actiza Parma Business Overview
- 4.13.3 Actiza Parma Pemetrexed Diacid Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Actiza Parma Pemetrexed Diacid Product Portfolio
- 4.13.5 Actiza Parma Recent Developments
5 Global Pemetrexed Diacid Market Scenario by Region
- 5.1 Global Pemetrexed Diacid Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pemetrexed Diacid Sales by Region: 2021-2032
- 5.2.1 Global Pemetrexed Diacid Sales by Region: 2021-2026
- 5.2.2 Global Pemetrexed Diacid Sales by Region: 2027-2032
- 5.3 Global Pemetrexed Diacid Revenue by Region: 2021-2032
- 5.3.1 Global Pemetrexed Diacid Revenue by Region: 2021-2026
- 5.3.2 Global Pemetrexed Diacid Revenue by Region: 2027-2032
- 5.4 North America Pemetrexed Diacid Market Facts & Figures by Country
- 5.4.1 North America Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Pemetrexed Diacid Sales by Country (2021-2032)
- 5.4.3 North America Pemetrexed Diacid Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Pemetrexed Diacid Market Facts & Figures by Country
- 5.5.1 Europe Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Pemetrexed Diacid Sales by Country (2021-2032)
- 5.5.3 Europe Pemetrexed Diacid Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Pemetrexed Diacid Market Facts & Figures by Country
- 5.6.1 Asia Pacific Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Pemetrexed Diacid Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Pemetrexed Diacid Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Pemetrexed Diacid Market Facts & Figures by Country
- 5.7.1 South America Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Pemetrexed Diacid Sales by Country (2021-2032)
- 5.7.3 South America Pemetrexed Diacid Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Pemetrexed Diacid Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Pemetrexed Diacid Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Pemetrexed Diacid Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Pemetrexed Diacid Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Pemetrexed Diacid Sales by Type (2021-2032)
- 6.1.1 Global Pemetrexed Diacid Sales by Type (2021-2032) & (doses)
- 6.1.2 Global Pemetrexed Diacid Sales Market Share by Type (2021-2032)
- 6.2 Global Pemetrexed Diacid Revenue by Type (2021-2032)
- 6.2.1 Global Pemetrexed Diacid Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Pemetrexed Diacid Revenue Market Share by Type (2021-2032)
- 6.3 Global Pemetrexed Diacid Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Pemetrexed Diacid Sales by Application (2021-2032)
- 7.1.1 Global Pemetrexed Diacid Sales by Application (2021-2032) & (doses)
- 7.1.2 Global Pemetrexed Diacid Sales Market Share by Application (2021-2032)
- 7.2 Global Pemetrexed Diacid Revenue by Application (2021-2032)
- 7.2.1 Global Pemetrexed Diacid Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Pemetrexed Diacid Revenue Market Share by Application (2021-2032)
- 7.3 Global Pemetrexed Diacid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Pemetrexed Diacid Value Chain Analysis
- 8.1.1 Pemetrexed Diacid Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Pemetrexed Diacid Production Mode & Process
- 8.2 Pemetrexed Diacid Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Pemetrexed Diacid Distributors
- 8.2.3 Pemetrexed Diacid Customers
9 Global Pemetrexed Diacid Analyzing Market Dynamics
- 9.1 Pemetrexed Diacid Industry Trends
- 9.2 Pemetrexed Diacid Industry Drivers
- 9.3 Pemetrexed Diacid Industry Opportunities and Challenges
- 9.4 Pemetrexed Diacid Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst